RENAISSANCE TECHNOLOGIES LLC
Follow13F filer, CIK 1037389, NEW YORK, NY
RENAISSANCE TECHNOLOGIES LLC reported $67,553,776,837 across 3,533 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-13. Its ten largest share positions make up 10.48% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001037389-25-000009
- Period
- 2024-12-31
- Reported value
- $67.6B
- Holdings
- 3,533
- Top 10 weight
- 10.48%
- New
- 570
- Sold out
- 521
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RDDTadded | +1,198,800 | $196M |
| NKEadded | +2,416,601 | $183M |
| BABAadded | +2,024,640 | $172M |
| SHOPnew | +1,568,800 | $167M |
| TSMadded | +780,822 | $154M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PLTRreduced | -15,629,431 | -$1.18B |
| MSFTreduced | -1,568,888 | -$678M |
| METAreduced | -597,566 | -$350M |
| AAPLreduced | -808,590 | -$202M |
| MUreduced | -2,399,952 | -$202M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Back to all 3,533 share positions
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| UUUUNIVERSAL SAFETY PRODS INC | 13,300 | $15.4K | shares |
| CBATCBAK ENERGY TECHNOLOGY INC | 11,100 | $13.9K | shares |
| MEIHUA INTL MED TECHNOLOGIESMEIHUA INTL MED TECHNOLOGIES | 13,200 | $13.5K | shares |
| GRYPHON DIGITAL MNG INCGRYPHON DIGITAL MNG INC | 17,500 | $11.9K | shares |
| INMED PHARMACEUTICALS INCINMED PHARMACEUTICALS INC | 50,296 | $11.9K | shares |
| S&W SEED COMPANY COMS&W SEED COMPANY COM | 53,620 | $9.92K | shares |
| UNIVERSE PHARMACEUTICALS INCUNIVERSE PHARMACEUTICALS INC | 39,267 | $9.58K | shares |
| FOCUS UNVL INCFOCUS UNVL INC | 35,215 | $9.3K | shares |
| ALPINE 4 HLDGS INC CLASS AALPINE 4 HLDGS INC CLASS A | 24,200 | $8.63K | shares |
| VCI GLOBAL LTDVCI GLOBAL LTD | 47,800 | $7.36K | shares |
| FORZA X1 INCFORZA X1 INC | 22,200 | $7.08K | shares |
| APTEVO THERAPEUTICS INCAPTEVO THERAPEUTICS INC | 36,575 | $6.58K | shares |
| OSTIN TECHNOLOGY GROUP CO LTOSTIN TECHNOLOGY GROUP CO LT | 14,900 | $5.6K | shares |
| Ensysce Biosciences IncEnsysce Biosciences Inc | 22,400 | $5.38K | shares |
| LDTCFLEDDARTECH HLDGS INC COM(CAN) | 17,700 | $5.22K | shares |
| 36KR HOLDINGS INC SPONSORED…36KR HOLDINGS INC SPONSORED ADR | 15,500 | $4.57K | shares |
| TIVIC HEALTH SYSTEMS INCTIVIC HEALTH SYSTEMS INC | 17,600 | $4.39K | shares |
| T STAMP INCT STAMP INC | 17,000 | $3.74K | shares |
| VIRIOS THERAPEUTICS INCVIRIOS THERAPEUTICS INC | 16,500 | $2.81K | shares |
| UPEXI INCUPEXI INC | 13,100 | $2.57K | shares |
| AGEAGLE AERIAL SYSTEMS INCO…AGEAGLE AERIAL SYSTEMS INCORPORAT… | 22,500 | $2.12K | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001037389-25-000009 | base | 2025-02-13 | acceptance time not in the bulk data set |